These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35326507)

  • 1. S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
    Treese C; Hartl K; Pötzsch M; Dahlmann M; von Winterfeld M; Berg E; Hummel M; Timm L; Rau B; Walther W; Daum S; Kobelt D; Stein U
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
    Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
    Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    J Mol Diagn; 2011 Mar; 13(2):189-98. PubMed ID: 21354054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer.
    Cho YG; Nam SW; Kim TY; Kim YS; Kim CJ; Park JY; Lee JH; Kim HS; Lee JW; Park CH; Song YH; Lee SH; Yoo NJ; Lee JY; Park WS
    APMIS; 2003 May; 111(5):539-45. PubMed ID: 12887505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
    Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
    Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer.
    Yonemura Y; Endou Y; Kimura K; Fushida S; Bandou E; Taniguchi K; Kinoshita K; Ninomiya I; Sugiyama K; Heizmann CW; Schafer BW; Sasaki T
    Clin Cancer Res; 2000 Nov; 6(11):4234-42. PubMed ID: 11106237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.
    Kortüm B; Radhakrishnan H; Zincke F; Sachse C; Burock S; Keilholz U; Dahlmann M; Walther W; Dittmar G; Kobelt D; Stein U
    Oncogene; 2022 Sep; 41(39):4446-4458. PubMed ID: 36008464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
    Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M
    Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
    Burock S; Daum S; Keilholz U; Neumann K; Walther W; Stein U
    BMC Cancer; 2018 Mar; 18(1):297. PubMed ID: 29544454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors.
    Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S
    Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.
    Lee OJ; Hong SM; Razvi MH; Peng D; Powell SM; Smoklin M; Moskaluk CA; El-Rifai W
    Neoplasia; 2006 Oct; 8(10):843-50. PubMed ID: 17032501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
    Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
    J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector.
    Chen D; Zhang R; Shen W; Fu H; Liu S; Sun K; Sun X
    Int J Oncol; 2013 May; 42(5):1763-9. PubMed ID: 23546393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.
    Yuan TM; Liang RY; Hsiao NW; Chuang SM
    Oncol Rep; 2014 Dec; 32(6):2307-18. PubMed ID: 25310523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of S100A4 gene encoding an S100-related calcium-binding protein in human bile duct adenocarcinoma cell lines: correlation of S100A4 expression and invasive growth in Matrigel Matrix.
    Katayama N; Murao S; Ajiki T; Kitazawa S; Onoyama H; Kuroda Y; Maeda S
    Int J Mol Med; 2000 Nov; 6(5):539-42. PubMed ID: 11029520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
    Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
    Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.